+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Immuno Oncology Assays Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Immunoassay, Flow Cytometry, Next-Generation Sequencing , Polymerase Chain Reaction ), By Product (Kits & Reagents, Instruments, Software), By Application (Drug Discovery & Development, Translational Research, Clinical Diagnostics), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations , Academic & Research Institutes, Hospitals & Diagnostic Centers) Companies, and Country Forecast, 2021 to 2034

Global Immuno Oncology Assays Market size is forecast to increase from $7.82 Billion in 2026 to $17.13 Billion in 2034 at a CAGR of 10.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007787
Pages: 225 Pages

Immune Repertoire Sequencing Market Size, Share and Growth Outlook, 2026: Analysis By Product (Consumables, Instruments, Software & Services), By Technology (Next-Generation Sequencing , Sanger Sequencing), By Application (Disease Research & Discovery, Vaccine Development, Clinical Diagnostics, Drug Development), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Immune Repertoire Sequencing Market size is forecast to increase from $419.36 Million in 2026 to $854.18 Million in 2034 at a CAGR of 9.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007786
Pages: 210 Pages

Immune Health Supplements Market Size, Share and Growth Outlook, 2026: Analysis By Ingredient (Vitamins & Minerals, Herbal & Botanical Extracts, Probiotics, Amino Acids & Proteins, Fatty Acids), By Form (Capsules & Tablets, Liquids, Powders, Gummies & Softgels), By Target Consumer (Children, Adults, Seniors), By Distribution Channel (Retail Pharmacies, Online Retailers, Supermarkets & Hypermarkets, Health & Wellness Stores) Companies, and Country Forecast, 2021 to 2034

Global Immune Health Supplements Market size is forecast to increase from $39.51 Billion in 2026 to $82.26 Billion in 2034 at a CAGR of 9.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007785
Pages: 229 Pages

Immune Checkpoint Inhibitors Market Size, Share and Growth Outlook, 2026: Analysis By Mechanism Target (Programmed Death Receptor-1 , Programmed Death-Ligand 1 , Cytotoxic T-Lymphocyte-Associated Antigen 4 , Emerging Inhibitors ), By Therapeutic Modality (Monoclonal Antibodies, Antibody Fragments, Combination Regimens , Small Molecule Inhibitors), By Clinical Indication (Lung Cancer , Melanoma & Skin Malignancies, Renal Cell & Bladder Carcinoma, Hodgkin Lymphoma & Hematologic Malignancies, Colorectal & Gastrointestinal Cancers, Head & Neck Cancers), By Route of Administration (Intravenous Infusion, Subcutaneous Injection), By Treatment Line (First-Line Therapy, Second-Line Therapy, Third-Line and Refractory Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialized Oncology Pharmacies & Infusion Centers) Companies, and Country Forecast, 2021 to 2034

Global Immune Checkpoint Inhibitors Market size is forecast to increase from $75.44 Billion in 2026 to $240.58 Billion in 2034 at a CAGR of 15.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007784
Pages: 225 Pages

Immune Cell Engineering Market Size, Share and Growth Outlook, 2026: Analysis By Cell Type (T Cells, Natural Killer , Dendritic Cells, Stem Cells, Tumor Cells), By Product Type (Consumables & Reagents, Engineering Instruments & Automated Hardware, Software & Data Analytics Platforms), By Technique (Gene Editing , Viral Transduction , Non-Viral Transfection ), By Therapeutic Application (Oncology & Hematological Malignancies, Autoimmune & Inflammatory Diseases, Infectious Diseases), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, Commercial Cell Banks & CMOs, Hospitals & Advanced Therapy Clinics) Companies, and Country Forecast, 2021 to 2034

Global Immune Cell Engineering Market size is forecast to increase from $5.43 Billion in 2026 to $18.68 Billion in 2034 at a CAGR of 16.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007783
Pages: 222 Pages

Immersive Technology in Healthcare Market Size, Share and Growth Outlook, 2026: Analysis By Technology Type (Virtual Reality , Augmented Reality , Mixed Reality ), By Component (Hardware , Software , Professional Services ), By Application (Medical Education & Student Training, Surgical Simulation & Pre-operative Planning, Patient Care & Pain Management, Rehabilitation & Physical Therapy, Mental Health Treatment & Exposure Therapy, Telemedicine & Immersive Telepresence), By End-User (Hospitals & Specialized Clinics, Academic Medical Centers & Research Institutes, Independent Rehabilitation Centers, Diagnostic & Outpatient Care Facilities) Companies, and Country Forecast, 2021 to 2034

Global Immersive Technology in Healthcare Market size is forecast to increase from $3.05 Billion in 2026 to $12.18 Billion in 2034 at a CAGR of 18.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007782
Pages: 227 Pages

Imatinib Drug Market Size, Share and Growth Outlook, 2026: Analysis By Drug Form (Tablets, Capsules), By Dosage (100 mg, 400 mg), By Application (Chronic Myeloid Leukemia , Acute Lymphoblastic Leukemia , Gastrointestinal Stromal Tumors , Myelodysplastic, Dermatofibrosarcoma Protuberans ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Imatinib Drug Market size is forecast to increase from $1.34 Billion in 2026 to $1.76 Billion in 2034 at a CAGR of 3.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007781
Pages: 216 Pages

Imaging Catheters Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Intravascular Ultrasound , Optical Coherence Tomography , Intracardiac Echocardiography , Electrophysiology ), By Modality (Ultrasound-based Imaging, Light-based Imaging), By Application (Cardiovascular Procedures , Neurological Interventions, Gastroenterology, Urology), By End-User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers , Specialty Diagnostic Centers) Companies, and Country Forecast, 2021 to 2034

Global Imaging Catheters Market size is forecast to increase from $1.7 Billion in 2026 to $2.53 Billion in 2034 at a CAGR of 5.11% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007780
Pages: 221 Pages

Imaging Biomarkers Market Size, Share and Growth Outlook, 2026: Analysis By Type (Functional Biomarkers, Morphological Biomarkers, Molecular Biomarkers, Metabolic Biomarkers), By Modality (Magnetic Resonance Imaging , Computed Tomography , Positron Emission Tomography , Single-Photon Emission Computed Tomography , Ultrasound), By Application (Oncology, Neurology, Cardiology, Musculoskeletal Disorders, Drug Discovery & Development), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Imaging Biomarkers Market size is forecast to increase from $17.38 Billion in 2026 to $48.89 Billion in 2034 at a CAGR of 13.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007779
Pages: 218 Pages

Image-guided Therapy Systems Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Ultrasound Systems, Endoscopes, Magnetic Resonance Imaging , X-ray Fluoroscopy, Positron Emission Tomography , Single-Photon Emission CT ), By Technology (Electromagnetic Navigation, Robotic-assisted Imaging Guidance, AI-Enhanced Real-time 3D, Augmented, Optical & Laser-based Tracking), By Application (Neurosurgery, Cardiac Surgery & Structural Heart, Orthopedic & Spine, Urology, Oncology & Ablation), By Modality Portability (Fixed Systems, Mobile C-arms, Hand-held), By End User (Hospitals and Clinics, Ambulatory Surgery Centers, Research and Academic Institutions) Companies, and Country Forecast, 2021 to 2034

Global Image-guided Therapy Systems Market size is forecast to increase from $5.77 Billion in 2026 to $8.76 Billion in 2034 at a CAGR of 5.36% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007778
Pages: 220 Pages